140 related articles for article (PubMed ID: 18823375)
41. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
[TBL] [Abstract][Full Text] [Related]
42. Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism.
Cai JP; Chen W; Hou X; Liang LJ; Hao XY; Yin XY
Anticancer Drugs; 2013 Nov; 24(10):1020-9. PubMed ID: 23941814
[TBL] [Abstract][Full Text] [Related]
43. [Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall].
Furuichi M; Muramatsu T; Shimamura M; Nishii T; Takeshita S; Ishimoto S; Morooka H; Sodeyama M; Sakurai K; Amano S; Ohmori I; Shiono M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):119-22. PubMed ID: 20087044
[TBL] [Abstract][Full Text] [Related]
44. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
45. [Gene-targeted radiation therapy mediated by radiation-sensitive promoter in lung adenocarcinoma and the feasibility of micro-PET/CT in evaluation of therapeutic effectiveness in small animals].
Xu H; Guo R; Jin Y; Li B
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):329-34. PubMed ID: 25030586
[TBL] [Abstract][Full Text] [Related]
46. [A case of pulmonary pleomorphic carcinoma treated with S-1 following radiotherapy].
Komatsu Y; Hama M; Shinagawa Y; Yoshikawa S; Gomi K; Yamashita K; Nakamura T; Honda T; Hachiya T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):687-9. PubMed ID: 22504704
[TBL] [Abstract][Full Text] [Related]
47. In vivo bioluminescence imaging monitoring of hypoxia-inducible factor 1alpha, a promoter that protects cells, in response to chemotherapy.
Viola RJ; Provenzale JM; Li F; Li CY; Yuan H; Tashjian J; Dewhirst MW
AJR Am J Roentgenol; 2008 Dec; 191(6):1779-84. PubMed ID: 19020250
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumab.
Masago K; Fujita S; Hata A; Kaji R; Ohtsuka K; Okuda C; Takeshita J; Katakami N
Anticancer Res; 2014 Dec; 34(12):7467-72. PubMed ID: 25503189
[TBL] [Abstract][Full Text] [Related]
49. [A case of gastric cancer complicated with multiple lung metastases responding to TS-1].
Ishiguro S; Iwabuchi H; Isobe N; Kawabe A; Yamasaki S; Yamamoto T
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1233-5. PubMed ID: 15332550
[TBL] [Abstract][Full Text] [Related]
50. [A case of hepatocellular carcinoma treated with TS-1].
Takemoto R; Shakado S; Yamashita N; Nishi H; Fukumori K; Fukuizumi K; Miyahara T; Sakai H; Yasumori K; Muranaka T; Takami Y; Saitsu H; Watanabe J; Sata M
Nihon Shokakibyo Gakkai Zasshi; 2003 Sep; 100(9):1123-8. PubMed ID: 14524239
[No Abstract] [Full Text] [Related]
51. Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.
Kruser TJ; Armstrong EA; Ghia AJ; Huang S; Wheeler DL; Radinsky R; Freeman DJ; Harari PM
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):534-42. PubMed ID: 18793955
[TBL] [Abstract][Full Text] [Related]
52. Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo.
Fukushima M; Sakamoto K; Sakata M; Nakagawa F; Saito H; Sakata Y
Oncol Rep; 2010 Nov; 24(5):1307-13. PubMed ID: 20878125
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft.
Li G; Xie B; Li X; Chen Y; Wang Q; Xu Y; Xu-Welliver M; Zou L
Cancer Biother Radiopharm; 2012 Feb; 27(1):56-64. PubMed ID: 22248028
[TBL] [Abstract][Full Text] [Related]
54. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
55. [A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Harada K; Kawashima Y; Uchida D; Yoshida H
Gan To Kagaku Ryoho; 2007 May; 34(5):745-7. PubMed ID: 17496449
[TBL] [Abstract][Full Text] [Related]
56. [An elderly patient with non-resectable lung cancer responding to TS-1].
Nakagawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1615-8. PubMed ID: 17108728
[TBL] [Abstract][Full Text] [Related]
57. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.
Zhang Y; Schwerbrock NM; Rogers AB; Kim WY; Huang L
Mol Ther; 2013 Aug; 21(8):1559-69. PubMed ID: 23774791
[TBL] [Abstract][Full Text] [Related]
58. Antisense oligonucleotide of hypoxia-inducible factor-1alpha suppresses growth and tumorigenicity of lung cancer cells A549.
Zhang W; Zhang H; Xing L
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):448-50. PubMed ID: 17120745
[TBL] [Abstract][Full Text] [Related]
59. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
Albert JM; Cao C; Geng L; Leavitt L; Hallahan DE; Lu B
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1536-43. PubMed ID: 16863930
[TBL] [Abstract][Full Text] [Related]
60. [A case of carcinoma associated with anal fistula resected after preoperative chemoradiotherapy].
Sato Y; Ohki S; Sassa M; Tachibana K; Ando J; Endo Y; Suzuki S; Nakamura I; Koyama Y; Suzuki S; Takenoshita S
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1341-3. PubMed ID: 21829077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
